NFJ-12950-69699
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 970 / OR
- Registered
- 2021-12-04
- Relationship
- Child or adolescent in my care
- Guardian
- ZLA-25397-83354
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-17
Dose 1 — Pfizer-BioNTech
-
2021-12-04
Registered in v-safe
-
2021-12-04
Survey response — day 14, dose 1, dependentMedDRA: Nasopharyngitis, Pain in extremity, Pyrexia — Feeling: GoodFree text: She had a sore arm (2 days), slight fever (24 hours), and cold symptoms (1 week) following the vaccine the next day.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-08
Dose 2 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-17 | Pfizer-BioNTech | No |
| 2 | 2021-12-08 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 1, dependent
Symptoms: She had a sore arm (2 days), slight fever (24 hours), and cold symptoms (1 week) following the vaccine the next day.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release